INTELLIA THERAPEUTICS, INC. Increase (Decrease) in Accounts Receivable
INTELLIA THERAPEUTICS, INC. (NTLA) reported Increase (Decrease) in Accounts Receivable of -$2.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- INTELLIA THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$1.81M, a 313.19% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$337.00K, a 116.96% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$1.58M.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$303.00K.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2025 was $951.00K.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2024 was -$27.94M, a 185.47% decline from fiscal 2023.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2023 was $32.69M, a 1781.87% increase from fiscal 2022.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2022 was $1.74M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.15M 10-Q · filed 2026-08-06 | -$3.73M derived: sum of 3 quarters · filed 2026-08-06 | -$4.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$337.00K 10-Q · filed 2026-05-11 | -$1.92M derived: sum of 2 quarters · filed 2026-05-11 | -$2.22M derived: sum of 3 quarters · filed 2026-05-11 | -$1.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.89M derived: sum of 2 quarters · filed 2026-02-26 | -$1.04M derived: sum of 3 quarters · filed 2026-08-06 | $951.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | -$303.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $546.00K derived: sum of 2 quarters · filed 2026-08-06 | $2.53M 10-Q · filed 2025-11-06 | $2.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $849.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.84M 10-Q · filed 2026-08-06 | $2.50M derived: sum of 3 quarters · filed 2026-08-06 | -$975.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.99M 10-Q · filed 2026-05-11 | $1.65M derived: sum of 2 quarters · filed 2026-05-11 | -$1.82M derived: sum of 3 quarters · filed 2026-05-11 | -$25.92M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$337.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.81M derived: sum of 2 quarters · filed 2026-02-26 | -$27.91M derived: sum of 3 quarters · filed 2026-02-26 | -$27.94M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$3.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$27.57M derived: sum of 2 quarters · filed 2025-11-06 | -$27.60M 10-Q · filed 2025-11-06 | $2.36M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$24.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$24.13M 10-Q · filed 2025-08-07 | $5.84M derived: sum of 3 quarters · filed 2026-02-26 | $7.27M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$29.00K 10-Q · filed 2025-05-08 | $29.94M derived: sum of 2 quarters · filed 2026-02-26 | $31.37M derived: sum of 3 quarters · filed 2026-02-26 | $31.52M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $29.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $31.40M derived: sum of 2 quarters · filed 2026-02-26 | $31.55M derived: sum of 3 quarters · filed 2026-02-26 | $32.69M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.58M derived: sum of 2 quarters · filed 2024-11-07 | $2.72M 10-Q · filed 2024-11-07 | $2.47M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.29M 10-Q · filed 2024-08-08 | $1.03M derived: sum of 3 quarters · filed 2025-02-27 | $2.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $1.14M 10-Q · filed 2024-05-09 | $883.00K derived: sum of 2 quarters · filed 2025-02-27 | $2.05M derived: sum of 3 quarters · filed 2025-02-27 | $3.10M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $913.00K derived: sum of 2 quarters · filed 2025-02-27 | $1.97M derived: sum of 3 quarters · filed 2025-02-27 | $1.74M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.22M derived: sum of 2 quarters · filed 2023-11-09 | $1.99M 10-Q · filed 2023-11-09 | $1.53M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $824.00K 10-Q · filed 2023-08-03 | $364.00K derived: sum of 3 quarters · filed 2024-02-22 | $862.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$230.00K 10-Q · filed 2023-05-04 | -$690.00K derived: sum of 2 quarters · filed 2024-02-22 | -$192.00K derived: sum of 3 quarters · filed 2024-02-22 | $848.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$460.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $38.00K derived: sum of 2 quarters · filed 2024-02-22 | $1.08M derived: sum of 3 quarters · filed 2024-02-22 | -$99.00K 10-K · filed 2024-02-22 |
| 2021-09-30 | $498.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.54M derived: sum of 2 quarters · filed 2022-11-03 | $361.00K 10-Q · filed 2022-11-03 | $1.27M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$137.00K 10-Q · filed 2022-08-04 | $776.00K derived: sum of 3 quarters · filed 2023-02-23 | -$1.87M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$1.18M 10-Q · filed 2022-05-05 | -$264.00K derived: sum of 2 quarters · filed 2023-02-23 | -$2.91M derived: sum of 3 quarters · filed 2023-02-23 | -$12.41M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $913.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$1.73M derived: sum of 2 quarters · filed 2023-02-23 | -$11.24M derived: sum of 3 quarters · filed 2023-02-23 | -$2.49M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$12.15M derived: sum of 2 quarters · filed 2021-11-04 | -$3.40M 10-Q · filed 2021-11-04 | -$2.38M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$9.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$756.00K 10-Q · filed 2021-08-05 | $265.00K derived: sum of 3 quarters · filed 2022-02-24 | -$324.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $8.75M 10-Q · filed 2021-05-06 | $9.77M derived: sum of 2 quarters · filed 2022-02-24 | $9.18M derived: sum of 3 quarters · filed 2022-02-24 | $9.78M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $432.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.03M derived: sum of 3 quarters · filed 2022-02-24 | -$2.93M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$589.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $8.00K derived: sum of 2 quarters · filed 2020-11-05 | -$3.95M 10-Q · filed 2020-11-05 | $786.00K derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $597.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$3.36M 10-Q · filed 2020-08-06 | $1.38M derived: sum of 3 quarters · filed 2021-02-26 | -$4.42M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$3.96M 10-Q · filed 2020-05-07 | $778.00K derived: sum of 2 quarters · filed 2021-02-26 | -$5.02M derived: sum of 3 quarters · filed 2021-02-26 | -$3.88M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $4.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$1.06M derived: sum of 2 quarters · filed 2021-02-26 | $81.00K derived: sum of 3 quarters · filed 2021-02-26 | -$2.92M 10-K · filed 2021-02-26 |
| 2018-09-30 | -$5.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$4.65M derived: sum of 2 quarters · filed 2019-10-31 | -$7.66M 10-Q · filed 2019-10-31 | -$1.68M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$1.86M 10-Q · filed 2019-08-01 | $4.12M derived: sum of 3 quarters · filed 2020-02-27 | $5.84M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$3.00M 10-Q · filed 2019-05-02 | $2.97M derived: sum of 2 quarters · filed 2020-02-27 | $4.70M derived: sum of 3 quarters · filed 2020-02-27 | $5.02M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $5.98M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $7.71M derived: sum of 2 quarters · filed 2020-02-27 | $8.03M derived: sum of 3 quarters · filed 2020-02-27 | $4.02M 10-K · filed 2020-02-27 |
| 2017-09-30 | $1.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $2.05M derived: sum of 2 quarters · filed 2018-10-31 | -$1.96M 10-Q · filed 2018-10-31 | $3.38M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $321.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$3.69M 10-Q · filed 2018-08-01 | $1.65M derived: sum of 3 quarters · filed 2019-02-27 | |
| 2017-03-31 | -$4.01M 10-Q · filed 2018-05-01 | $1.33M derived: sum of 2 quarters · filed 2019-02-27 | ||
| 2016-12-31 | $5.34M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $5.45M 10-K · filed 2019-02-27 | ||
| 2016-09-30 | $112.00K 10-Q · filed 2017-10-31 | |||
| 2015-12-31 | $1.01M 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |